Serina Therapeutics (SER) Cash from Operations (2018 - 2025)
Serina Therapeutics (SER) posted Cash from Operations of 6055000.0 for Q4 2025, down 58.18% sequentially from 3828000.0 in Q3 2025, and down 31.95% YoY from 8897340.7 in Q4 2024.
Serina Therapeutics (SER) Cash from Operations (2018 - 2025) Analysis & Trends
Serina Therapeutics has reported Cash from Operations for 8 years, with the latest figure at 6055000.0 in Q4 2025.
- Quarterly Cash from Operations fell 31.95% year-over-year to 6055000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 17955000.0 (down 4.77% YoY) and the FY2025 annual result came in at 17955000.0, down 4.77% from the prior year.
- Cash from Operations slipped to 6055000.0 in Q4 2025 per SER's latest filing, from 3828000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 121000.0 in Q4 2023 and troughed at 8009000.0 in Q2 2024.
- A 5-year average of 2568100.0 and a median of 1765000.0 in 2021 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2023 and 2024: Cash from Operations jumped 109.16% in 2023, then sank 3892.56% in 2024.
- Over 5 years, Cash from Operations stood at 1737000.0 in 2021, then rose by 23.95% to 1321000.0 in 2022, then soared by 109.16% to 121000.0 in 2023, then tumbled by 3892.56% to 4589000.0 in 2024, then sank by 31.95% to 6055000.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered 6055000.0, 3828000.0, and 3750000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 326.72 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -88.83 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 728.46 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.27 Mn |
| 10 | Serina Therapeutics | 43.17 Mn | 20.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.06 Mn |
| Dec 31, 2025 | -6.06 Mn |
| Sep 30, 2025 | -3.83 Mn |
| Sep 30, 2025 | -3.83 Mn |
| Jun 30, 2025 | -3.75 Mn |
| Jun 30, 2025 | -3.75 Mn |
| Mar 31, 2025 | -4.32 Mn |
| Mar 31, 2025 | -4.32 Mn |
| Dec 31, 2024 | -4.59 Mn |
| Dec 31, 2024 | -4.59 Mn |
| Sep 30, 2024 | -2.96 Mn |
| Sep 30, 2024 | -2.96 Mn |
| Jun 30, 2024 | -8.01 Mn |
| Jun 30, 2024 | -8.01 Mn |
| Mar 31, 2024 | -1.58 Mn |
| Mar 31, 2024 | -1.58 Mn |
| Dec 31, 2023 | 121,000.00 |
| Dec 31, 2023 | 121,000.00 |
| Sep 30, 2023 | -1.02 Mn |
| Sep 30, 2023 | -1.02 Mn |